Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Xiqingguo Granules is a traditional Chinese medicine (TCM) formulation developed and marketed by Anhui Jiuhua Huayuan Pharmaceutical. The primary active ingredient is Xiqingguo (the immature fruit of *Terminalia chebula* Retz.), which is traditionally used in Chinese medicine for its heat-clearing and throat-soothing properties. It is specifically indicated for clearing heat, relieving sore throat, and promoting fluid production. Clinical applications include the treatment of dry throat, sore throat, and pharyngeal congestion caused by yin deficiency and internal heat injury, as well as chronic pharyngitis and chronic tonsillitis. The product is administered orally as granules dissolved in warm water.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Xiqingguo Granules.